Description of screening programme Clause Samples

Description of screening programme. Screening for Down’s, ▇▇▇▇▇▇▇’ and Patau’s syndromes is part of the NHS Fetal Anomaly Screening Programme (FASP). In line with NICE guidance (Clinical guideline 62 Antenatal care June 2010 ▇▇▇▇://▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇▇.▇▇▇.▇▇/antenatal-care-cg62 all pregnant women should be offered an early ultrasound scan to determine gestational age. The NHS Screening programme’s recommended screening tests are gestation dependent, and are as follows: • between 10+0 and 14+1 weeks of pregnancy the combined test, which consists of a nuchal translucency scan and a blood test that measures two specific maternal biochemical markers for use in screening for Down’s, ▇▇▇▇▇▇▇’ and Patau’s syndromes. • between 14+2 to 20+0 weeks the quadruple test which measures four maternal biochemical markers for use in screening for Down’s syndrome only To complete the ultrasound component of this screening strategy, the scan appointment should allocate time to incorporate pre-scan counselling, the ultrasound examination, post- scan counselling and reporting. The time allocation for appointments to meet these requirements is a minimum of twenty (20) minutes. The results of either test give an individual risk assessment to the woman on the possibility that her baby/ies will have Down’s, ▇▇▇▇▇▇▇’ or Patau’s syndromes. If the risk of having a term pregnancy affected with any of these syndromes is 1 in 150 or higher, the pregnancy is regarded as higher risk and the woman will be offered a prenatal diagnostic (PND) test. In delivering a national screening programme and to ensure national consistency the local Provider is expected to fulfill the following, in conjunction with guidance from the National Screening Programme where appropriate and as detailed in the standards and policies available on ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/fetal-anomaly-screening- programme-standards • work to nationally agreed common standards and policies • be required to implement and support national IT developments • use materials provided by the national screening programme, e.g. leaflets, training media and protocols for their use • be required to respond to national action/lessons such as change of software, equipment supplier, techniques • work with NHS England in reporting, investigating and resolving screening incidents • provide data and reports against programme standards, key performance indicators (KPIs), and quality indicators as required by the national screening programme on behalf of the NHS Screening...

Description of screening programme. The Fetal Anomaly Screening Programme recommend a mid-pregnancy scan which is undertaken between 18+0 to 20+6 weeks of pregnancy to screen for major fetal anomalies. The examination should be undertaken in accordance with the requirements of the FASP guidance (Anatomical Base Menu and Fetal Cardiac Protocol) ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/publications/fetal-anomaly-screening-programme- handbook . The first scan is an early pregnancy scan performed from 8+0 weeks gestation and is used mainly for dating the pregnancy and confirming viability. The second scan is undertaken between 18+0 to 20+6 weeks of pregnancy and screens for major structural abnormalities. The 11 auditable conditions currently screened for are: • Anencephaly; • Open ▇▇▇▇▇ bifida; • Cleft lip; • Diaphragmatic hernia; • Gastroschisis; • Exomphalos; • Serious cardiac abnormalities; • Bilateral renal agenesis; • Lethal skeletal dysplasia; • ▇▇▇▇▇▇▇’ syndrome (Trisomy 13) • Patau’s syndrome (Trisomy 18) The ultrasound scan appointment should incorporate pre-scan counselling, the ultrasound examination, post-scan counselling and reporting. The time allocation for appointments to meet these requirements for a ▇▇▇▇▇▇▇▇▇ pregnancy is a minimum of thirty (30) minutes and for a multiple pregnancy is forty five (45) minutes. In delivering a national screening programme and to ensure national consistency the local Provider is expected to fulfil the following, in conjunction with guidance from the national programme where appropriate and as detailed in the standard and policies available On ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇/government/collections/nhs-population-screening-programme- standards • work to nationally agreed common standards and policies • be required to implement and support national IT developments • use materials provided by the national screening programme, e.g. leaflets, training media and protocols for their use • be required to respond to national action/lessons such as change of software, equipment supplier, techniques • work with NHS England in reporting on and resolving safety incidents • provide data and reports against programme standards, key performance indicators (KPIs), and quality indicators as required by the national screening programme • take part in quality assurance processes and implement changes recommended by QA including urgent suspension of services if required • implement and monitor failsafe procedures and continuously ensure quality • work with bordering Providers to ensure that...

Description of screening programme. The UK National Screening Committee (UK NSC) policy for NIPE is that all eligible babies will be offered the NIPE screen. The screen should be offered within 72 hours of birth and then again at 6-8 weeks of age. The universal offer of screening facilitates early detection of congenital defects of the heart, hips, eyes and testes. Any abnormalities suspected or detected and any clinical concerns identified will lead to a prompt referral for early clinical assessment by the relevant clinical expert. In delivering a national screening programme and to ensure national consistency the local provider is expected to fulfil the following, in conjunction with guidance from the national screening programme where appropriate and as detailed in national policy and standards  work to nationally agreed standards and policies  be required to implement and support national IT developments  be required to respond to national actions such as change of IT software, equipment supplier and techniques  ensure appropriate governance structures are in place  implement and monitor failsafe procedures and continuously ensure quality and safety  work with bordering providers to ensure that handover of results or patients is smooth and robust  provide data and reports mapped against programme standards, key performance indicators, and quality indicators as required  take part in quality assurance (QA) processes and implement changes recommended by QA including urgent suspension of services if required  work with the NHS in reporting , investigating and resolving screening safety incidents and implement agreed actions  ensure all health care professionals access and complete appropriate training to maintain continuous professional development and competency  use materials provided by the national screening programme, e.g. information leaflets, e-learning and other training resources, and policies to support local service delivery  participate in evaluation of the screening programme

Description of screening programme. The UK NSC policy on newborn hearing screening is that all eligible newborn babies in England should be offered screening for bilateral permanent hearing impairment (sensorineural or permanent conductive). Screening should be offered to all babies up to 3 months of age although ideally screening should be performed within days of birth. Those older than 3 months of age, or otherwise not eligible for screening, should be considered for referral to audiology. In delivering a national programme and to ensure national consistency, the local provider is expected to fulfil the following, in conjunction with guidance from the national screening programme where appropriate and as detailed in the programme guidance. • work to nationally agreed programme standards, policies, recommended guidance and pathways • be required to implement and support national IT developments • be required to respond to national actions/lessons such as change of software, equipment supplier, techniques • ensure appropriate governance structures are in place • implement and monitor checks and audit procedures and continuously ensure quality and safety • work with bordering providers to ensure that handover of results or patients is smooth and robust • provide data and reports against programme standards, key performance indicators (KPIs), and quality indicators as required • take part in quality assurance processes and implement changes recommended by QA including urgent suspension of services if required • work with NHS England and NHS Improvement in reporting, investigating and resolving screening incidents and implement agreed actions in accordance to the Managing Safety Incidents in NHS Screening Programmes • provide evidence that all healthcare professionals access and complete appropriate training to maintain continuous professional development and competency • use materials provided by the national programme, e.g. information, leaflets, training resources and guidance • participate in evaluation of the screening programme

Description of screening programme. The provider is expected to follow, guidance from the national screening programme as detailed in the standards and policies To make sure there is national consistency the provider should: • work to national screening standards • provide data and reports against screening standards, key performance indicators (KPIs), and other measures as requested by the national screening programme • provide data on screening outcomes as required by the national screening programme • make sure appropriate governance structures are in place • take part in quality assurance (QA) processes and implement changes recommended by QA including urgent suspension of services if required • implement and monitor joint checks and audit mechanisms where required to ensure safe and timely processes across the whole screening pathway and drive continuous quality improvement • work with NHS England and NHS Improvement and the screening quality assurance service (SQAS) in reporting, investigating and managing screening safety incidents • respond to national action/lessons for example, change of software, equipment or equipment supplier, new technologies • make sure all health care professionals access appropriate training to maintain continuous professional development and competency • use materials provided by the national screening programme, for example, leaflets, e-learning resources and operational guidance • implement and support national IT developments Screening for Down’s syndrome, ▇▇▇▇▇▇▇’ syndrome and Patau’s syndrome is part of the NHS Fetal Anomaly Screening Programme (FASP). In line with NICE guidance (Clinical guideline 62 Antenatal care), all pregnant women should be offered an early ultrasound scan to determine gestational age. The NHS screening programme’s recommended screening tests are gestation dependent, and are as follows: • the combined test can be performed when the crown rump length (CRL) is between 45.0mm to 84.0mm which corresponds to 11+2 to 14+1 weeks of gestation. If the ultrasound measurement shows that the CRL is less than 45.0mm, the woman should be recalled for a further scan to measure the nuchal translucency (NT) • If the CRL is greater than 84.0mm, the second trimester quadruple test should be offered. • the quadruple test which measures four maternal biochemical markers for use in screening for Down’s syndrome only can be performed when the head circumference (HC) is equal to or more than 101.0mm (between 14+2 to 20+0 weeks of pregnancy),